Singapore a magnet for big pharma

With Singapore continuing to attract top pharmaceutical companies, clinical research and biomedical manufacturing opportunities abound. Indeed between 2000 and 2015, the number of clinical research programs conducted in Singapore jumped by 30%. Today, six out of the top 10 drugs produced globally are made in Singapore.

The growth is driven by the country’s advanced manufacturing capabilities, by the increasing demand among an affluent population for personalized, novel medicine and for an increasingly highly trained workforce.